Anesthesia Drugs Market by Type, Route of Administration, and Geography - Forecast and Analysis - 2023-2027

Published: Jan 2023 Pages: 165 SKU: IRTNTR74926

The anesthesia drugs market is estimated to grow at a CAGR of 4.35% between 2022 and 2027. The size of the market is forecast to increase by USD 1,383.65 million. The growth of the market depends on several factors, including the rising prevalence of cancer, the increasing number of surgeries, and the rising elderly population.

This report extensively covers market segmentation by type (general anesthesia, local, and regional anesthesia), route of administration (intravenous, inhalational, and others), and geography (North America, Europe, Asia, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.

What will be the size of the Anesthesia Drugs Market During the Forecast Period?

To learn more about this report, Download Report Sample

Parent Market Analysis

The reports categorize the global anesthesia drugs market as a part of the global pharmaceuticals market within the overall healthcare industry. The parent, the global pharmaceuticals market covers products and companies engaged in research and development (R&D) or production of generic drugs, non-generic drugs, and veterinary drugs.  Our research report has extensively covered external factors influencing the parent market growth during the forecast period.

Anesthesia Drugs Market: Key Drivers, Trends, Challenges, and Customer Landscape

The rising prevalence of cancer is notably driving the market growth, although factors such as growing demand for general anesthetic risks in pediatric patients and pregnant women may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Anesthesia Drugs Market Driver

The rising prevalence of cancer is notably driving market growth. Cancer has become much more common in recent decades. According to the National Cancer Institute, there were approximately 17 million cancer survivors in the US in 2020, and it is expected to reach 22.2 million by 2030. Breast cancer, lung and bronchus cancer, prostate cancer, colon and rectum cancer, melanoma of the skin, bladder cancer, non-Hodgkin lymphoma, kidney and renal pelvis cancer, endometrial cancer, pancreatic cancer, thyroid cancer, and liver cancer are the most common cancers.

In 2022, an estimated 1.9 million new cancer cases were diagnosed. Since cancer surgery provides the best opportunity for a cure for many tumors, especially if the cancer is confined, the increased prevalence of cancer will lead to an increase in the number of procedures. As a result of the increasing frequency of cancer, the general anesthesia market will grow, as general anesthesia is often used for surgical operations to treat cancer. Therefore, the rising prevalence of cancer is expected to drive the growth of the market during the forecast period.

Significant Anesthesia Drugs Market Trend

Rapidly expanding healthcare infrastructure is the primary trend in the market. The cost of healthcare expenditure is increasing in developing and developed countries. Anesthesia is generally covered by health insurance for all medical procedures. For patients with medical insurance, the out-of-pocket cost for anesthesia is around 10% to 50%. In addition, rapidly expanding healthcare infrastructure in multiple developing and developed countries can potentially drive the market. As healthcare infrastructure expands, the number of surgeries and procedures performed also increases, which, in turn, drives the demand for anesthesia drugs.

The increase in healthcare expenditure by the governments of developing and developed countries can open new markets for anesthesia drugs as more and more people gain access to surgical procedures and other medical treatments that require anesthesia. It will also lead to an increase in the number of hospitals and clinics with more advanced and sophisticated equipment and technology which is expected to fuel the demand for anesthesia drugs. Thus, an increase in the healthcare infrastructure is expected to fuel the growth of the market during the forecast period.

Major Anesthesia Drugs Market Challenge

General anesthetic risks in pediatric patients and pregnant women are the major challenges impeding market growth. The use of pharmacologic agents, particularly general anesthetic drugs, in pediatric patients necessitates extra caution. Infants and young children respond differently to anesthetic drugs than adults due to a variety of characteristics such as body composition, protein binding, body temperature, cardiac output distribution, and functional maturity of the liver and kidneys.

Various investigations have found that using general anesthetics and sedative medicines in pregnant and young animals for more than 3 hours caused extensive nerve cell death in the brain. Anesthesia can cause decreased blood flow to the uterus, which can lead to fetal distress or even death. Additionally, anesthesia can lead to respiratory depression, which can cause harm to both the mother and the fetus. Thus, due to the risk associated with the use of general anesthetics by healthcare providers, the market may face challenges during the forecast period.

Key Anesthesia Drugs Market Customer Landscape

The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Anesthesia Drugs Market Customer Landscape

Who are the Major Anesthesia Drugs Market Vendors?

Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Septodont Holding - The company offers anesthesia drugs such as Sevoflurane, Desflurane, Isoflurane through its subsidiary Piramal Critical Care. This segment focuses on developing, manufacturing, and distributing a wide range of high-quality dental products all over the world.

The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:

  • AbbVie Inc.
  • Aspen Pharmacare Holdings Ltd
  • AstraZeneca Plc
  • Avet Pharmaceuticals Inc.
  • Baxter International Inc.
  • Dr Reddys Laboratories Ltd.
  • Eisai Co. Ltd.
  • Endo International Plc
  • Fresenius SE and Co. KGaA
  • Glenmark Pharmaceuticals Ltd.
  • Hikma Pharmaceuticals Plc
  • Maruishi Pharmaceutical Co. Ltd.
  • Merck and Co. Inc.
  • Novartis AG
  • PAION AG

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

What is the Fastest-Growing Segment in the Anesthesia Drugs Market?

The market share growth of the general anesthesia segment will be significant during the forecast period. General anesthesia is a type of anesthesia that induces a loss of consciousness and sensation throughout the entire body. It is commonly used for major surgical procedures, such as open-heart surgery or complex orthopedic surgery, as well as for some non-surgical procedures, such as endoscopy or radiation therapy.

Get a glance at the market contribution of various segments Request a PDF Sample

The general anesthesia segment was valued at USD 3,336.51 million in 2017 and continued to grow until 2021. General anesthesia drugs hold the largest market share and are expected to hold the dominance due to the increasing number of major surgeries worldwide, as they have assisted doctors in developing individualized anesthetic plans that balance the patient's history with the anticipated surgical plan, maximizing patient safety, which, in turn, will boost the growth of the market during the forecast period.

Which are the Key Regions for the Anesthesia Drugs Market?

For more insights on the market share of various regions Request PDF Sample now!

North America is estimated to contribute 32% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

The anesthesia drugs market in North America is expected to grow at a steady growth rate due to the increasing number of surgical procedures in the region. In this region, ailments such as cancer, heart disease, and cardiovascular disease are highly prevalent and increasing at a rapid pace. According to the American Cancer Society's Cancer Facts and Figures, In 2021, there were 1.9 million cancer cases in the US. Furthermore, according to the most recent National Cancer Institute data, breast malignancy is the most frequent cancer, with 290,560 new cases expected in the US. The next most common malignancies in the US are prostate cancer and lung cancer. This cancer load is expected to increase the number of cancer procedures. This is expected to contribute to the demand generation for anesthesia drugs, which, in turn, will drive the growth of the market during the forecast period.

The outbreak of COVID-19 negatively affected the economies of various countries in North America, especially the US. However, in 2021, business and industrial activities resumed with the lifting of stringent lockdown restrictions due to the availability of COVID-19 vaccines and the vaccination drives carried out by the governments of different countries, such as the US, Canada, and Mexico. This has encouraged people to go for health checkups and various surgeries such as heart and orthopedic surgical operations, which has increased the demand for anesthesia drugs in North America.

Segment Overview

The report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • Deployment Outlook (USD Million, 2017 - 2027)
    • General anesthesia
    • Local and regional anesthesia
  • Route Of Administration Outlook (USD Million, 2017 - 2027)
    • Intravenous
    • Inhalational
    • Others
  • Region Outlook (USD Million, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of World (ROW)
      • Argentina
      • Brazil
      • Rest of the Middle East & Africa

Anesthesia Drugs Market Scope

Report Coverage

Details

Page number

165

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 4.35%

Market growth 2023-2027

USD 1,383.65 million

Market structure

Fragmented

YoY growth 2022-2023(%)

4.04

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 32%

Key countries

US, Germany, UK, China, and India

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

AbbVie Inc., Aspen Pharmacare Holdings Ltd, AstraZeneca Plc, Avet Pharmaceuticals Inc., Baxter International Inc., Dr Reddys Laboratories Ltd., Eisai Co. Ltd., Endo International Plc, Fresenius SE and Co. KGaA, Glenmark Pharmaceuticals Ltd., Hikma Pharmaceuticals Plc, Maruishi Pharmaceutical Co. Ltd., Merck and Co. Inc., Novartis AG, PAION AG, Pfizer Inc., Piramal Enterprises Ltd., Septodont Holding, Troikaa Pharmaceuticals Ltd., and B Braun Melsungen AG

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Anesthesia Drugs Market Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the anesthesia drugs market between 2023 and 2027
  • Precise estimation of the anesthesia drugs market size and its contribution to the parent market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the industry across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough analysis of the market’s competitive landscape and detailed information about vendors
  • Comprehensive analysis of factors that will challenge the growth of anesthesia drugs market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Route of Administration
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global anesthesia drugs market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on Global anesthesia drugs market 2017 - 2021 ($ million)
    • 4.2 Type Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Type Segment 2017 - 2021 ($ million)
    • 4.3 Route of Administration Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Route of Administration Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Type

    • 6.1 Market segments
      • Exhibit 30: Chart on Type - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
    • 6.2 Comparison by Type
      • Exhibit 32: Chart on Comparison by Type
      • Exhibit 33: Data Table on Comparison by Type
    • 6.3 General anesthesia - Market size and forecast 2022-2027
      • Exhibit 34: Chart on General anesthesia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on General anesthesia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on General anesthesia - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on General anesthesia - Year-over-year growth 2022-2027 (%)
    • 6.4 Local and regional anesthesia - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Local and regional anesthesia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Local and regional anesthesia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Local and regional anesthesia - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Local and regional anesthesia - Year-over-year growth 2022-2027 (%)
    • 6.5 Market opportunity by Type
      • Exhibit 42: Market opportunity by Type ($ million)

    7 Market Segmentation by Route of Administration

    • 7.1 Market segments
      • Exhibit 43: Chart on Route of Administration - Market share 2022-2027 (%)
      • Exhibit 44: Data Table on Route of Administration - Market share 2022-2027 (%)
    • 7.2 Comparison by Route of Administration
      • Exhibit 45: Chart on Comparison by Route of Administration
      • Exhibit 46: Data Table on Comparison by Route of Administration
    • 7.3 Intravenous - Market size and forecast 2022-2027
      • Exhibit 47: Chart on Intravenous - Market size and forecast 2022-2027 ($ million)
      • Exhibit 48: Data Table on Intravenous - Market size and forecast 2022-2027 ($ million)
      • Exhibit 49: Chart on Intravenous - Year-over-year growth 2022-2027 (%)
      • Exhibit 50: Data Table on Intravenous - Year-over-year growth 2022-2027 (%)
    • 7.4 Inhalational - Market size and forecast 2022-2027
      • Exhibit 51: Chart on Inhalational - Market size and forecast 2022-2027 ($ million)
      • Exhibit 52: Data Table on Inhalational - Market size and forecast 2022-2027 ($ million)
      • Exhibit 53: Chart on Inhalational - Year-over-year growth 2022-2027 (%)
      • Exhibit 54: Data Table on Inhalational - Year-over-year growth 2022-2027 (%)
    • 7.5 Others - Market size and forecast 2022-2027
      • Exhibit 55: Chart on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 56: Data Table on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 57: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 58: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 7.6 Market opportunity by Route of Administration
      • Exhibit 59: Market opportunity by Route of Administration ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 61: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 62: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 63: Chart on Geographic comparison
      • Exhibit 64: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 Germany - Market size and forecast 2022-2027
      • Exhibit 85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.9 UK - Market size and forecast 2022-2027
      • Exhibit 89: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 90: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 91: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 92: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.10 China - Market size and forecast 2022-2027
      • Exhibit 93: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 94: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 95: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 96: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.11 India - Market size and forecast 2022-2027
      • Exhibit 97: Chart on India - Market size and forecast 2022-2027 ($ million)
      • Exhibit 98: Data Table on India - Market size and forecast 2022-2027 ($ million)
      • Exhibit 99: Chart on India - Year-over-year growth 2022-2027 (%)
      • Exhibit 100: Data Table on India - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 101: Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 102: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 104: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 105: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 106: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 107: Matrix on vendor position and classification
            • 12.3 AbbVie Inc.
              • Exhibit 108: AbbVie Inc. - Overview
              • Exhibit 109: AbbVie Inc. - Product / Service
              • Exhibit 110: AbbVie Inc. - Key news
              • Exhibit 111: AbbVie Inc. - Key offerings
            • 12.4 AstraZeneca Plc
              • Exhibit 112: AstraZeneca Plc - Overview
              • Exhibit 113: AstraZeneca Plc - Product / Service
              • Exhibit 114: AstraZeneca Plc - Key news
              • Exhibit 115: AstraZeneca Plc - Key offerings
            • 12.5 Avet Pharmaceuticals Inc.
              • Exhibit 116: Avet Pharmaceuticals Inc. - Overview
              • Exhibit 117: Avet Pharmaceuticals Inc. - Product / Service
              • Exhibit 118: Avet Pharmaceuticals Inc. - Key offerings
            • 12.6 B Braun Melsungen AG
              • Exhibit 119: B Braun Melsungen AG - Overview
              • Exhibit 120: B Braun Melsungen AG - Business segments
              • Exhibit 121: B Braun Melsungen AG - Key news
              • Exhibit 122: B Braun Melsungen AG - Key offerings
              • Exhibit 123: B Braun Melsungen AG - Segment focus
            • 12.7 Baxter International Inc.
              • Exhibit 124: Baxter International Inc. - Overview
              • Exhibit 125: Baxter International Inc. - Business segments
              • Exhibit 126: Baxter International Inc. - Key news
              • Exhibit 127: Baxter International Inc. - Key offerings
              • Exhibit 128: Baxter International Inc. - Segment focus
            • 12.8 Eisai Co. Ltd.
              • Exhibit 129: Eisai Co. Ltd. - Overview
              • Exhibit 130: Eisai Co. Ltd. - Business segments
              • Exhibit 131: Eisai Co. Ltd. - Key offerings
              • Exhibit 132: Eisai Co. Ltd. - Segment focus
            • 12.9 Fresenius SE and Co. KGaA
              • Exhibit 133: Fresenius SE and Co. KGaA - Overview
              • Exhibit 134: Fresenius SE and Co. KGaA - Business segments
              • Exhibit 135: Fresenius SE and Co. KGaA - Key news
              • Exhibit 136: Fresenius SE and Co. KGaA - Key offerings
              • Exhibit 137: Fresenius SE and Co. KGaA - Segment focus
            • 12.10 Glenmark Pharmaceuticals Ltd.
              • Exhibit 138: Glenmark Pharmaceuticals Ltd. - Overview
              • Exhibit 139: Glenmark Pharmaceuticals Ltd. - Product / Service
              • Exhibit 140: Glenmark Pharmaceuticals Ltd. - Key offerings
            • 12.11 Hikma Pharmaceuticals Plc
              • Exhibit 141: Hikma Pharmaceuticals Plc - Overview
              • Exhibit 142: Hikma Pharmaceuticals Plc - Business segments
              • Exhibit 143: Hikma Pharmaceuticals Plc - Key offerings
              • Exhibit 144: Hikma Pharmaceuticals Plc - Segment focus
            • 12.12 Maruishi Pharmaceutical Co. Ltd.
              • Exhibit 145: Maruishi Pharmaceutical Co. Ltd. - Overview
              • Exhibit 146: Maruishi Pharmaceutical Co. Ltd. - Product / Service
              • Exhibit 147: Maruishi Pharmaceutical Co. Ltd. - Key offerings
            • 12.13 Merck and Co. Inc.
              • Exhibit 148: Merck and Co. Inc. - Overview
              • Exhibit 149: Merck and Co. Inc. - Business segments
              • Exhibit 150: Merck and Co. Inc. - Key news
              • Exhibit 151: Merck and Co. Inc. - Key offerings
              • Exhibit 152: Merck and Co. Inc. - Segment focus
            • 12.14 Novartis AG
              • Exhibit 153: Novartis AG - Overview
              • Exhibit 154: Novartis AG - Business segments
              • Exhibit 155: Novartis AG - Key offerings
              • Exhibit 156: Novartis AG - Segment focus
            • 12.15 Pfizer Inc.
              • Exhibit 157: Pfizer Inc. - Overview
              • Exhibit 158: Pfizer Inc. - Product / Service
              • Exhibit 159: Pfizer Inc. - Key news
              • Exhibit 160: Pfizer Inc. - Key offerings
            • 12.16 Piramal Enterprises Ltd.
              • Exhibit 161: Piramal Enterprises Ltd. - Overview
              • Exhibit 162: Piramal Enterprises Ltd. - Business segments
              • Exhibit 163: Piramal Enterprises Ltd. - Key offerings
              • Exhibit 164: Piramal Enterprises Ltd. - Segment focus
            • 12.17 Septodont Holding
              • Exhibit 165: Septodont Holding - Overview
              • Exhibit 166: Septodont Holding - Product / Service
              • Exhibit 167: Septodont Holding - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 168: Inclusions checklist
                • Exhibit 169: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 170: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 171: Research methodology
                • Exhibit 172: Validation techniques employed for market sizing
                • Exhibit 173: Information sources
              • 13.5 List of abbreviations
                • Exhibit 174: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              anesthesia drugs market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis